Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors
Jackson, Christopher B, Noorbakhsh, Seth I, Sundaram, Ranjini K, Kalathil, Aravind N, Ganesa, Sachita, Jia, Lanqi, Breslin, Hank, Burgenske, Danielle M, Gilad, Oren, Sarkaria, Jann N, Bindra, Ranjit S
Published in Cancer research (Chicago, Ill.) (01.09.2019)
Published in Cancer research (Chicago, Ill.) (01.09.2019)
Get full text
Journal Article
Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors
Sule, Amrita, Van Doorn, Jinny, Sundaram, Ranjini K, Ganesa, Sachita, Vasquez, Juan C, Bindra, Ranjit S
Published in NAR cancer (01.06.2021)
Published in NAR cancer (01.06.2021)
Get full text
Journal Article